JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuda, H.
Right arrow Articles by Katoh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuda, H.
Right arrow Articles by Katoh, A.
Journal of Nuclear Medicine Vol. 43 No. 3 304-311
© 2002 by Society of Nuclear Medicine


Clinical Investigations

Longitudinal Evaluation of Both Morphologic and Functional Changes in the Same Individuals with Alzheimer’s Disease

Hiroshi Matsuda, MD1, Noriyuki Kitayama, MD2,3, Takashi Ohnishi, MD1, Takashi Asada, MD4, Seigo Nakano, MD5, Shigeki Sakamoto, MD1, Etsuko Imabayashi, MD1 and Asako Katoh, MD1

1 Department of Radiology, National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center of Neurology and Psychiatry, Tokyo, Japan
2 Department of Radiology, University of Washington Medical Center, Seattle, Washington
3 Department of Psychiatry, Showa University School of Medicine, Tokyo, Japan
4 Department of Neuropsychiatry, Tsukuba University, Ibaraki, Japan
5 Department of Geriatric Medicine, National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center of Neurology and Psychiatry, Tokyo, Japan

Morphologic and functional imaging studies have not always given concordant results about brain areas showing atrophic changes and reduced flow or metabolism in Alzheimer’s disease (AD). The aim of this study was to determine the initial abnormality and the longitudinal changes in both morphologic and functional measurements for the same individuals with AD. Methods: We investigated 15 patients with mild AD and 25 age-matched healthy volunteers. The AD patients underwent both MRI and SPECT 3 times at intervals of approximately 1 y. The gray matter volume, as segmented from MRI, and the regional cerebral blood flow (rCBF), as measured by SPECT, of AD patients were compared with those of healthy volunteers using statistical parametric mapping, which is a voxel-based analysis in stereotactic space. Results: Considerable discordance between areas of regional atrophy and areas of decreased rCBF was observed. The medial temporal areas showed a faster and more extensive reduction of gray matter volume than of rCBF. In comparison with the value at the baseline study, rCBF in the posterior cingulate gyrus and precuneus and the associative parietal cortex was extensively decreased. In contrast, the extent of significant decrease in this area continued to be much narrower for gray matter volume than for rCBF, even in the follow-up studies. Frontal areas, including the anterior cingulate gyrus and the orbitofrontal areas, showed a progressive reduction in both rCBF and gray matter volume. The reduction in rCBF was in a more posterior part of the associative temporal cortex than was the reduction in gray matter volume. Conclusion: These results indicate a distinct discordance between morphologic and functional changes in a longitudinal study of AD. Functional changes may be caused partly by remote effects from the morphologically involved areas with decreased connectivity and partly by a compensatory response by neuronal plasticity.

Key Words: Alzheimer’s disease • SPECT • MRI • statistical parametric mapping




This article has been cited by other articles:


Home page
NeurologyHome page
J. L. Whitwell, K. A. Josephs, M. E. Murray, K. Kantarci, S. A. Przybelski, S. D. Weigand, P. Vemuri, M. L. Senjem, J. E. Parisi, D. S. Knopman, et al.
MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study
Neurology, September 2, 2008; 71(10): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Villain, B. Desgranges, F. Viader, V. de la Sayette, F. Mezenge, B. Landeau, J.-C. Baron, F. Eustache, and G. Chetelat
Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease
J. Neurosci., June 11, 2008; 28(24): 6174 - 6181.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Chetelat, B. Desgranges, B. Landeau, F. Mezenge, J. B. Poline, V. de la Sayette, F. Viader, F. Eustache, and J.-C. Baron
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
Brain, January 1, 2008; 131(1): 60 - 71.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
R I SCAHILL and N C FOX
Longitudinal imaging in dementia
Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S92 - S98.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
K. L. Lanctot, D. F. Hussey, N. Herrmann, S. E. Black, P. M. Rusjan, A. A. Wilson, S. Houle, N. Kozloff, N. P. L.G. Verhoeff, and S. Kapur
A Positron Emission Tomography Study of 5-Hydroxytryptamine-1A Receptors in Alzheimer Disease
Am J Geriatr Psychiatry, October 1, 2007; 15(10): 888 - 898.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Matsuda
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
J. Nucl. Med., August 1, 2007; 48(8): 1289 - 1300.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Whitwell, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
Brain, July 1, 2007; 130(7): 1777 - 1786.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. J. Kim, S. S. Cho, Y. Jeong, K. C. Park, S. J. Kang, E. Kang, S. E. Kim, K. H. Lee, and D. L. Na
Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients
Brain, August 1, 2005; 128(8): 1790 - 1801.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Guedj, D. Taieb, C. De Laforte, M. Ceccaldi, O. Mundler, Y. Krausz, N. Freedman, and O. Bonne
Similitude of Brain Perfusion Pattern in Hypothyroidism and Early Alzheimer's Disease: Physiopathologic Considerations
J. Nucl. Med., July 1, 2005; 46(7): 1247 - 1248.
[Full Text] [PDF]


Home page
Cereb CortexHome page
J. P. Lerch, J. C. Pruessner, A. Zijdenbos, H. Hampel, S. J. Teipel, and A. C. Evans
Focal Decline of Cortical Thickness in Alzheimer's Disease Identified by Computational Neuroanatomy
Cereb Cortex, July 1, 2005; 15(7): 995 - 1001.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
N. A. Johnson, G.-H. Jahng, M. W. Weiner, B. L. Miller, H. C. Chui, W. J. Jagust, M. L. Gorno-Tempini, and N. Schuff
Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience
Radiology, March 1, 2005; 234(3): 851 - 859.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
C. Summerfield, C. Junque, E. Tolosa, P. Salgado-Pineda, B. Gomez-Anson, M. J. Marti, P. Pastor, B. Ramirez-Ruiz, and J. Mercader
Structural Brain Changes in Parkinson Disease With Dementia: A Voxel-Based Morphometry Study
Arch Neurol, February 1, 2005; 62(2): 281 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
N. Hirono, M. Hashimoto, K. Ishii, H. Kazui, and E. Mori
One-Year Change in Cerebral Glucose Metabolism in Patients With Alzheimer's Disease
J Neuropsychiatry Clin Neurosci, November 1, 2004; 16(4): 488 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Mosconi, B Nacmias, S Sorbi, M T R De Cristofaro, M Fayazz, A Tedde, L Bracco, K Herholz, and A Pupi
Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 370 - 376.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Chetelat, B. Desgranges, V. de la Sayette, F. Viader, K. Berkouk, B. Landeau, C. Lalevee, F. Le Doze, B. Dupuy, D. Hannequin, et al.
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
Brain, September 1, 2003; 126(9): 1955 - 1967.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.